(+)-alpha-Bisabolol decreases activity EXP 6480464 bisabolol results in decreased activity of CYP2B1 protein CTD PMID:15936245 (+)-artemisinin increases expression ISO RGD:1558311 6480464 artemisinin results in increased expression of CYP2B10 mRNA CTD PMID:16919048 , PMID:17962186 (+)-artemisinin increases activity ISO RGD:1558311 6480464 artemisinin results in increased activity of CYP2B10 protein CTD PMID:16919048 (+)-artemisinin increases expression EXP 6480464 artemisinin results in increased expression of CYP2B1 mRNA CTD PMID:16919048 , PMID:36356836 (+)-catechin multiple interactions ISO RGD:1558311 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA CTD PMID:25663641 (+)-epicatechin-3-O-gallate multiple interactions ISO RGD:1558311 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA CTD PMID:25663641 (+)-isoborneol increases expression EXP 6480464 isoborneol results in increased expression of CYP2B1 mRNA CTD PMID:27889497 (-)-anisomycin multiple interactions ISO RGD:1558311 6480464 Anisomycin promotes the reaction [[1 more ... CTD PMID:23539296 (-)-cotinine increases abundance EXP 6480464 CYP2B1 protein results in increased abundance of Cotinine CTD PMID:10799646 (-)-cotinine multiple interactions EXP 6480464 [Nicotine results in increased expression of CYP2B1 protein] which results in increased abundance of Cotinine CTD PMID:10799646 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1558311 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA CTD PMID:25663641 (1->4)-beta-D-glucan multiple interactions ISO RGD:1558311 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP2B10 mRNA CTD PMID:36331819 (R)-camphor decreases activity EXP 6480464 Camphor results in decreased activity of CYP2B1 protein CTD PMID:9242356 (R,R,R)-alpha-tocopherol decreases expression ISO RGD:1558311 6480464 alpha-Tocopherol results in decreased expression of CYP2B10 mRNA CTD PMID:26102010 (S)-nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 2 more ... CTD PMID:10799646 more ... (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of CYP2B1 mRNA, Nicotine results in increased expression of CYP2B1 protein CTD PMID:10799646 , PMID:14972772 (S)-nicotine increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Nicotine CTD PMID:10799646 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases hydroxylation EXP 6480464 CYP2B1 protein results in increased hydroxylation of 1 more ... CTD PMID:12167570 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO RGD:1558311 6480464 o, p'-DDT affects the expression of CYP2B10 mRNA CTD PMID:18925944 1,2,4,5-tetrachlorobenzene increases expression EXP 6480464 1 more ... CTD PMID:10696772 1,2-dichloroethane increases expression ISO RGD:1558311 6480464 ethylene dichloride results in increased expression of CYP2B10 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dichloroethene affects expression EXP 6480464 1, 2-dichloroethylene affects the expression of CYP2B1 protein CTD PMID:9493318 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of CYP2B1 mRNA CTD PMID:32387197 1,4-benzoquinone affects expression EXP 6480464 quinone affects the expression of CYP2B1 protein CTD PMID:10462055 1,4-dichlorobenzene increases expression EXP 6480464 4-dichlorobenzene results in increased expression of CYP2B1 protein CTD PMID:9325029 1,4-dichlorobenzene increases expression ISO RGD:1558311 6480464 4-dichlorobenzene results in increased expression of CYP2B10 mRNA CTD PMID:28541575 1,4-dioxane multiple interactions EXP 6480464 1, 4-dioxane results in increased expression of and results in increased activity of CYP2B1 protein CTD PMID:15490126 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CYP2B1 mRNA more ... CTD PMID:30723492 , PMID:32198087 1-naphthyl isothiocyanate multiple interactions EXP 6480464 ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA] more ... CTD PMID:32198087 17alpha-ethynylestradiol affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Ethinyl Estradiol CTD PMID:16485904 17alpha-ethynylestradiol decreases expression ISO RGD:1558311 6480464 Ethinyl Estradiol results in decreased expression of CYP2B10 mRNA CTD PMID:27818225 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with NADP] results in decreased activity of CYP2B1 protein CTD PMID:11805216 , PMID:16485904 17alpha-ethynylestradiol increases expression ISO RGD:1558311 6480464 Ethinyl Estradiol results in increased expression of CYP2B10 mRNA CTD PMID:12948398 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of CYP2B1 protein CTD PMID:15178696 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP2B1 mRNA CTD PMID:7513451 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP2B1 mRNA CTD PMID:35192832 17beta-estradiol multiple interactions ISO RGD:1558311 6480464 Estradiol promotes the reaction [GADD45B protein binds to CYP2B10 promoter] more ... CTD PMID:23684557 17beta-estradiol increases expression ISO RGD:1558311 6480464 Estradiol results in increased expression of CYP2B10 mRNA CTD PMID:11075820 more ... 17beta-estradiol affects expression ISO RGD:1558311 6480464 Estradiol affects the expression of CYP2B10 mRNA CTD PMID:7771797 19-Nor-17alpha-pregn-5(10)-en-20-yne-3alpha,17beta-diol increases expression EXP 6480464 17alpha-ethynylestr-5(10)-ene-3alpha, 17beta-diol results in increased expression of CYP2B1 mRNA CTD PMID:7513451 2,2',3,3',6,6'-hexachlorobiphenyl increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:22026639 2,2',3,3',6,6'-hexachlorobiphenyl decreases expression ISO RGD:1558311 6480464 2 more ... CTD PMID:28431184 2,2',3,3',6,6'-hexachlorobiphenyl increases expression ISO RGD:1558311 6480464 2 more ... CTD PMID:28431184 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:1558311 6480464 2 more ... CTD PMID:17324954 more ... 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:15223772 , PMID:23770461 2,2',4,4',5,5'-hexachlorobiphenyl increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to 2 more ... CTD PMID:10640525 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:17160104 more ... 2,2',4,4',5,5'-hexachlorobiphenyl increases activity EXP 6480464 2 more ... CTD PMID:1372805 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1558311 6480464 [2 more ... CTD PMID:23457121 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:16107549 more ... 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:1558311 6480464 2 more ... CTD PMID:17324954 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1558311 6480464 2 more ... CTD PMID:17324954 more ... 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 [CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,2',5,5'-tetrachlorobiphenyl increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to 2 more ... CTD PMID:10640525 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23770461 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [2 more ... CTD PMID:23770461 2,3',4,4',5-Pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:17342196 2,3',4,4',5-Pentachlorobiphenyl increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of 2 more ... CTD PMID:27208082 2,3,4,3',4'-Pentachlorobiphenyl increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to 2 more ... CTD PMID:10640525 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1558311 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:18835339 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2B1 mRNA CTD PMID:28433708 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1558311 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2B10 mRNA CTD PMID:17627975 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1558311 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2B10 mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2B1 mRNA CTD PMID:16054898 , PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1558311 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2B10 mRNA CTD PMID:19770486 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:1558311 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP2B1 protein CTD PMID:18835339 2,4,6-Triphenyl-1-hexene decreases expression ISO RGD:1558311 6480464 2 more ... CTD PMID:18560529 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions EXP 6480464 [CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:16107549 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of CYP2B1 mRNA, Butylated Hydroxytoluene results in increased expression of CYP2B1 protein CTD PMID:15110098 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO RGD:1558311 6480464 Verapamil results in decreased activity of CYP2B10 protein CTD PMID:18420780 2-acetamidofluorene decreases expression EXP 6480464 2-Acetylaminofluorene analog results in decreased expression of CYP2B1 protein, 2-Acetylaminofluorene results in decreased expression of CYP2B1 protein CTD PMID:15916741 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CYP2B1 protein CTD PMID:10445401 2-nitrotoluene increases expression ISO RGD:1558311 6480464 2-nitrotoluene results in increased expression of CYP2B10 mRNA CTD PMID:15618236 2-Oxohexane increases activity EXP 6480464 Methyl n-Butyl Ketone results in increased activity of CYP2B1 protein CTD PMID:1372805 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of CYP2B1 protein CTD PMID:12806184 3,3',4,4',5-pentachlorobiphenyl increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to 3 more ... CTD PMID:10640525 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1558311 6480464 3 more ... CTD PMID:30312631 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1558311 6480464 3 more ... CTD PMID:30312631 3,3',4,4',5-pentachlorobiphenyl increases activity EXP 6480464 3 more ... CTD PMID:16628245 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:17160104 more ... 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of CYP2B1 protein CTD PMID:24278553 3,3',5,5'-tetrabromobisphenol A affects expression EXP 6480464 tetrabromobisphenol A affects the expression of CYP2B1 mRNA CTD PMID:26988606 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP 6480464 [tetrabromobisphenol A results in increased expression of CYP2B1 protein] which results in increased abundance of Reactive Oxygen Species CTD PMID:24278553 3,3'-diindolylmethane increases expression EXP 6480464 3, 3'-diindolylmethane results in increased expression of CYP2B1 protein CTD PMID:8384853 3,5-diethoxycarbonyl-1,4-dihydrocollidine increases expression ISO RGD:1558311 6480464 3 more ... CTD PMID:21826054 3-methylbenzyl alcohol decreases activity EXP 6480464 3-methylbenzyl alcohol results in decreased activity of CYP2B1 protein CTD PMID:12791539 3-methylcholanthrene multiple interactions EXP 6480464 Methylcholanthrene promotes the reaction [Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP2B1 protein] CTD PMID:18486174 3-methylcholanthrene decreases expression ISO RGD:1558311 6480464 Methylcholanthrene results in decreased expression of CYP2B10 mRNA CTD PMID:30503582 3-methylcholanthrene affects expression EXP 6480464 Methylcholanthrene affects the expression of CYP2B1 mRNA CTD PMID:23273579 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases activity EXP 6480464 musk ketone results in increased activity of CYP2B1 protein CTD PMID:10630706 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone multiple interactions ISO RGD:1558311 6480464 musk ketone inhibits the reaction [Phenobarbital results in increased activity of CYP2B1 protein] CTD PMID:9441723 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression ISO RGD:1558311 6480464 musk ketone results in increased expression of CYP2B1 mRNA, musk ketone results in increased expression of CYP2B1 protein CTD PMID:9441723 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression EXP 6480464 musk ketone results in increased expression of CYP2B1 mRNA, musk ketone results in increased expression of CYP2B1 protein CTD PMID:10630706 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases activity ISO RGD:1558311 6480464 musk ketone results in increased activity of CYP2B1 protein CTD PMID:9441723 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CYP2B1 mRNA CTD PMID:30723492 4,4'-methylene-bis-(2-chloroaniline) increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of Methylenebis(chloroaniline) CTD PMID:2908851 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases activity EXP 6480464 CYP2B1 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:10799646 4-nonylphenol increases expression ISO RGD:1558311 6480464 4-nonylphenol results in increased expression of CYP2B10 mRNA CTD PMID:17483497 4-nonylphenol multiple interactions ISO RGD:1558311 6480464 4-nonylphenol promotes the reaction [NR1I3 protein results in increased expression of CYP2B6 mRNA] more ... CTD PMID:17483497 4-Vinylcyclohexene multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of 4-vinylcyclohexene] which results in increased abundance of 1, 2-epoxy-4-vinylcyclohexane CTD PMID:11368546 4-Vinylcyclohexene increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of 4-vinylcyclohexene CTD PMID:11368546 5,5-diethylbarbituric acid increases activity EXP 6480464 Barbital results in increased activity of CYP2B1 protein CTD PMID:7697745 5,7-dihydroxy-4'-methoxyflavone decreases activity EXP 6480464 acacetin results in decreased activity of CYP2B1 protein CTD PMID:32738202 5-fluorouracil multiple interactions EXP 6480464 [CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil], [CYP2B1 co-treated with CDA] results in increased susceptibility to Fluorouracil CTD PMID:10811482 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP2B1 mRNA, Omeprazole results in increased expression of CYP2B1 protein CTD PMID:19118567 , PMID:9152597 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases activity ISO RGD:1558311 6480464 Omeprazole results in decreased activity of CYP2B10 protein CTD PMID:18420780 5-methoxyindole decreases activity ISO RGD:1558311 6480464 5-methoxyindole results in decreased activity of CYP2B10 protein CTD PMID:18420780 5alpha-androst-16-en-3alpha-ol multiple interactions ISO RGD:1558311 6480464 [1 more ... CTD PMID:20361990 6-propyl-2-thiouracil multiple interactions ISO RGD:1558311 6480464 [Iodine deficiency co-treated with Propylthiouracil] results in increased expression of CYP2B10 mRNA CTD PMID:22503787 7,12-dimethyltetraphene increases activity EXP 6480464 9 more ... CTD PMID:16054776 7,12-dimethyltetraphene multiple interactions EXP 6480464 beta-Naphthoflavone inhibits the reaction [9 more ... CTD PMID:16054776 acephate multiple interactions ISO RGD:1558311 6480464 [acephate co-treated with vinclozolin] affects the expression of CYP2B1 protein more ... CTD PMID:17686559 acetone decreases expression EXP 6480464 Acetone results in decreased expression of CYP2B1 protein CTD PMID:8267643 acetonitrile multiple interactions EXP 6480464 acetonitrile inhibits the reaction [CYP2B1 protein results in increased metabolism of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19858067 acifluorfen increases expression ISO RGD:1558311 6480464 acifluorfen results in increased expression of CYP2B10 mRNA CTD PMID:26928356 acifluorfen multiple interactions ISO RGD:1558311 6480464 NR1I3 gene mutant form inhibits the reaction [acifluorfen results in increased expression of CYP2B10 mRNA] CTD PMID:26928356 actinomycin D multiple interactions ISO RGD:1558311 6480464 Dactinomycin inhibits the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] CTD PMID:9007836 aflatoxin B1 multiple interactions EXP 6480464 CYP2B1 protein affects the metabolism of and results in increased activity of Aflatoxin B1 CTD PMID:10357798 aflatoxin B1 decreases expression ISO RGD:1558311 6480464 Aflatoxin B1 results in decreased expression of CYP2B10 mRNA CTD PMID:19770486 aflatoxin B1 increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to Aflatoxin B1 CTD PMID:2125692 AICA ribonucleotide multiple interactions EXP 6480464 AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA], PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]] CTD PMID:22815988 alachlor multiple interactions EXP 6480464 alachlor results in increased expression of and results in increased activity of CYP2B1 protein CTD PMID:11850968 all-trans-retinoic acid decreases activity ISO RGD:1558311 6480464 Tretinoin results in decreased activity of CYP2B10 protein CTD PMID:18420780 allyl alcohol increases expression EXP 6480464 allyl alcohol results in increased expression of CYP2B1 protein CTD PMID:10445401 allyl isothiocyanate multiple interactions ISO RGD:1558311 6480464 allyl isothiocyanate inhibits the reaction [[1 more ... CTD PMID:25069801 alpha-hexachlorocyclohexane multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in increased activity of CYP2B1 protein more ... CTD PMID:11165752 , PMID:16246485 alpha-hexachlorocyclohexane increases activity EXP 6480464 alpha-hexachlorocyclohexane results in increased activity of CYP2B1 protein CTD PMID:1372805 alpha-pinene decreases activity EXP 6480464 alpha-pinene results in decreased activity of CYP2B1 protein CTD PMID:9242356 amiodarone increases expression ISO RGD:1558311 6480464 Amiodarone results in increased expression of CYP2B10 mRNA CTD PMID:24535564 amitraz increases expression EXP 6480464 amitraz results in increased expression of CYP2B1 protein CTD PMID:15350676 , PMID:31029719 amitriptyline increases expression EXP 6480464 Amitriptyline results in increased expression of CYP2B1 mRNA CTD PMID:10945841 amitrole multiple interactions EXP 6480464 Amitrole inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:11353799 , PMID:14722249 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP2B1 mRNA CTD PMID:16483693 andrographolide increases activity ISO RGD:1558311 6480464 andrographolide results in increased activity of CYP2B10 protein CTD PMID:21094198 andrographolide increases expression ISO RGD:1558311 6480464 andrographolide results in increased expression of CYP2B10 mRNA CTD PMID:19737545 andrographolide multiple interactions ISO RGD:1558311 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B10 mRNA CTD PMID:19737545 androst-4-ene-3,17-dione decreases expression ISO RGD:1558311 6480464 Androstenedione results in decreased expression of CYP2B10 mRNA CTD PMID:11075820 androst-4-ene-3,17-dione increases expression ISO RGD:1558311 6480464 Androstenedione results in increased expression of CYP2B10 mRNA CTD PMID:7771797 androstane multiple interactions ISO RGD:1558311 6480464 [Androstanols co-treated with fulvestrant] inhibits the reaction [DDT results in increased expression of CYP2B10 mRNA] more ... CTD PMID:12807759 , PMID:23684557 aniline multiple interactions EXP 6480464 [Phenobarbital results in increased expression of CYP2B1 protein] which results in increased metabolism of aniline CTD PMID:9010585 Aroclor 1254 increases activity EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased activity of CYP2B1 protein CTD PMID:8471063 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2B1 mRNA, Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2B1 protein CTD PMID:11163329 , PMID:8471063 arsane multiple interactions ISO RGD:1558311 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP2B10 mRNA CTD PMID:32045263 arsenic atom multiple interactions ISO RGD:1558311 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP2B10 mRNA CTD PMID:32045263 aspartame multiple interactions EXP 6480464 Aspartame results in increased expression of and results in increased activity of CYP2B1 protein CTD PMID:16937917 atorvastatin calcium increases expression ISO RGD:1558311 6480464 Atorvastatin results in increased expression of CYP2B10 mRNA, Atorvastatin results in increased expression of CYP2B10 protein CTD PMID:15986414 atrazine multiple interactions ISO RGD:1558311 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 protein, Lycopene promotes the reaction [Atrazine results in increased expression of CYP2B10 mRNA] CTD PMID:22515965 , PMID:36216167 atrazine increases expression ISO RGD:1558311 6480464 Atrazine results in increased expression of CYP2B10 mRNA CTD PMID:36216167 atrazine decreases expression ISO RGD:1558311 6480464 Atrazine results in decreased expression of CYP2B1 mRNA CTD PMID:26775023 barbiturates increases activity EXP 6480464 Barbiturates results in increased activity of CYP2B1 protein CTD PMID:1372805 benzene increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Benzene CTD PMID:8211999 benzene increases expression EXP 6480464 Benzene results in increased expression of CYP2B1 protein CTD PMID:8135039 , PMID:9010585 benzene multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone more ... CTD PMID:8211999 , PMID:9118895 benzo[a]pyrene multiple interactions EXP 6480464 [3-xylene results in decreased activity of CYP2B1 protein] which affects the metabolism of Benzo(a)pyrene, [Phenobarbital co-treated with Benzo(a)pyrene] results in increased expression of CYP2B1 mRNA CTD PMID:1949897 , PMID:25489928 benzo[a]pyrene multiple interactions ISO RGD:1558311 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CYP2B10 mRNA] CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1558311 6480464 Benzo(a)pyrene results in increased expression of CYP2B10 mRNA, Benzo(a)pyrene results in increased expression of CYP2B10 protein CTD PMID:22228805 more ... benzo[b]fluoranthene increases expression ISO RGD:1558311 6480464 benzo(b)fluoranthene results in increased expression of CYP2B10 mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression ISO RGD:1558311 6480464 benzo(k)fluoranthene results in increased expression of CYP2B10 mRNA CTD PMID:26377693 benzophenone increases expression EXP 6480464 benzophenone results in increased expression of CYP2B1, benzophenone results in increased expression of CYP2B1 mRNA CTD PMID:14613717 , PMID:22584684 berberine multiple interactions ISO RGD:1558311 6480464 Berberine inhibits the reaction [Streptozocin results in increased expression of CYP2B10 mRNA], Berberine promotes the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] CTD PMID:22342832 berberine increases expression ISO RGD:1558311 6480464 Berberine results in increased expression of CYP2B10 mRNA CTD PMID:22342832 bergomottin increases expression ISO RGD:1558311 6480464 bergamottin results in increased expression of CYP2B10 protein CTD PMID:18692084 beta-hexachlorocyclohexane increases expression ISO RGD:1558311 6480464 beta-hexachlorocyclohexane results in increased expression of CYP2B10 mRNA CTD PMID:25270620 beta-myrcene decreases activity EXP 6480464 beta-myrcene results in decreased activity of CYP2B1 protein CTD PMID:9242356 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP2B1 mRNA, beta-Naphthoflavone results in increased expression of CYP2B1 protein CTD PMID:15588932 , PMID:15607757 beta-naphthoflavone increases activity EXP 6480464 beta-Naphthoflavone results in increased activity of CYP2B1 protein CTD PMID:16054776 beta-naphthoflavone multiple interactions EXP 6480464 beta-Naphthoflavone inhibits the reaction [9 more ... CTD PMID:16054776 beta-naphthoflavone multiple interactions ISO RGD:1558311 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP2B10 mRNA CTD PMID:19737545 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of CYP2B1 mRNA CTD PMID:23292798 bilobalide increases expression EXP 6480464 bilobalide results in increased expression of CYP2B1 mRNA, bilobalide results in increased expression of CYP2B1 protein CTD PMID:16258077 , PMID:18421621 biphenyl-4-amine increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of 4-biphenylamine CTD PMID:2908851 bis(2-chloroethyl) sulfide increases expression ISO RGD:1558311 6480464 Mustard Gas results in increased expression of CYP2B10 mRNA CTD PMID:15674844 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1558311 6480464 Diethylhexyl Phthalate results in increased expression of CYP2B10 mRNA CTD PMID:17627975 more ... bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1558311 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:19850644 , PMID:30722647 bisphenol A multiple interactions ISO RGD:1558311 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28123100 , PMID:30722647 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP2B1 mRNA CTD PMID:35192832 bisphenol A increases expression ISO RGD:1558311 6480464 bisphenol A results in increased expression of CYP2B10 mRNA CTD PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP2B1 mRNA CTD PMID:30903817 bitertanol increases expression EXP 6480464 bitertanol results in increased expression of CYP2B1 protein CTD PMID:16971034 bromodichloromethane increases expression EXP 6480464 bromodichloromethane results in increased expression of CYP2B1 protein CTD PMID:11295256 bromodichloromethane increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of bromodichloromethane CTD PMID:11295256 , PMID:12076521 bromodichloromethane decreases expression EXP 6480464 bromodichloromethane results in decreased expression of CYP2B1 protein CTD PMID:11295256 bromuconazole decreases expression EXP 6480464 bromuconazole results in decreased expression of CYP2B1 CTD PMID:28532222 brucine increases expression EXP 6480464 brucine results in increased expression of CYP2B1 protein CTD PMID:7906730 bupropion increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Bupropion CTD PMID:28438436 bupropion multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Bupropion] which results in increased chemical synthesis of hydroxybupropion CTD PMID:28438436 bupropion increases metabolic processing ISO RGD:1558311 6480464 CYP2B10 protein results in increased metabolism of Bupropion CTD PMID:25623066 bupropion multiple interactions ISO RGD:1558311 6480464 [ABCB6 gene mutant form results in decreased expression of CYP2B10 mRNA] inhibits the reaction [CYP2B10 protein results in increased metabolism of Bupropion], [ABCB6 gene mutant form results in decreased expression of CYP2B10 protein] inhibits the reaction [CYP2B10 protein results in increased metabolism of Bupropion] CTD PMID:25623066 buta-1,3-diene increases expression ISO RGD:1558311 6480464 1, 3-butadiene results in increased expression of CYP2B10 mRNA CTD PMID:29038090 butylated hydroxyanisole increases expression ISO RGD:1558311 6480464 Butylated Hydroxyanisole results in increased expression of CYP2B10 mRNA CTD PMID:17627975 Butylbenzyl phthalate increases expression ISO RGD:1558311 6480464 butylbenzyl phthalate results in increased expression of CYP2B10 mRNA CTD PMID:26519955 Butylbenzyl phthalate decreases activity EXP 6480464 butylbenzyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 Butylparaben decreases activity EXP 6480464 butylparaben results in decreased activity of CYP2B1 protein CTD PMID:27432241 C.I. Natural Red 20 decreases activity EXP 6480464 shikonin results in decreased activity of CYP2B1 protein CTD PMID:28941798 camphor decreases activity EXP 6480464 Camphor results in decreased activity of CYP2B1 protein CTD PMID:9242356 cannabidiol decreases activity ISO RGD:1558311 6480464 Cannabidiol results in decreased activity of CYP2B10 CTD PMID:8043019 cannabidiol increases expression ISO RGD:1558311 6480464 Cannabidiol results in increased expression of CYP2B10 mRNA CTD PMID:31052254 cannabidiol multiple interactions ISO RGD:1558311 6480464 [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CYP2B10 mRNA CTD PMID:33096940 captan multiple interactions ISO RGD:1558311 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA, [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA CTD PMID:32736067 , PMID:32745781 captan increases expression ISO RGD:1558311 6480464 Captan results in increased expression of CYP2B10 mRNA CTD PMID:31558096 carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of CYP2B1 mRNA CTD PMID:16125621 carbon monoxide multiple interactions EXP 6480464 Carbon Monoxide inhibits the reaction [CYP2B1 protein results in increased reduction of sodium chromate(VI)] CTD PMID:1903091 Chalepensin increases expression ISO RGD:1558311 6480464 3-(alpha, alpha-dimethylallyl)psoralen results in increased expression of CYP2B10 mRNA CTD PMID:22790670 chloral hydrate multiple interactions EXP 6480464 Chloral Hydrate inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:7513451 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of CYP2B1 mRNA CTD PMID:7513451 chlordecone increases expression ISO RGD:1558311 6480464 Chlordecone results in increased expression of CYP2B10 mRNA CTD PMID:33711761 chlordecone multiple interactions ISO RGD:1558311 6480464 Chlordecone results in increased expression of and results in increased activity of CYP2B10 protein CTD PMID:8722114 chlordecone multiple interactions EXP 6480464 Chlordecone inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:7513451 chlorobenzene multiple interactions EXP 6480464 [Phenobarbital results in increased expression of CYP2B1 protein] which results in increased metabolism of chlorobenzene CTD PMID:9010585 chlorpromazine multiple interactions ISO RGD:1558311 6480464 NR1I3 protein affects the reaction [Chlorpromazine results in increased expression of CYP2B10 mRNA] CTD PMID:12049174 chlorpyrifos increases expression ISO RGD:1558311 6480464 Chlorpyrifos results in increased expression of CYP2B6 protein CTD PMID:22515965 chlorpyrifos decreases expression ISO RGD:1558311 6480464 Chlorpyrifos results in decreased expression of CYP2B10 mRNA CTD PMID:29935250 chlorpyrifos affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Chlorpyrifos CTD PMID:15587241 chlorpyrifos decreases activity EXP 6480464 Chlorpyrifos results in decreased activity of CYP2B1 protein CTD PMID:15587241 chlorpyrifos multiple interactions ISO RGD:1558311 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 protein more ... CTD PMID:22515965 more ... chlorzoxazone affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Chlorzoxazone CTD PMID:15879494 cholesterol decreases activity ISO RGD:1558311 6480464 Cholesterol results in decreased activity of CYP2B10 protein CTD PMID:18420780 cholic acid increases expression ISO RGD:1558311 6480464 Cholic Acid results in increased expression of CYP2B10 mRNA CTD PMID:17521389 choline multiple interactions EXP 6480464 Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP2B1 protein], Choline deficiency promotes the reaction [Phenobarbital results in increased expression of CYP2B1 protein] CTD PMID:18798224 choline multiple interactions ISO RGD:1558311 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA more ... CTD PMID:22872676 more ... chrysin multiple interactions ISO RGD:1558311 6480464 NR1I3 gene mutant form inhibits the reaction [chrysin results in increased expression of CYP2B10 mRNA] CTD PMID:25625231 chrysin increases expression ISO RGD:1558311 6480464 chrysin results in increased expression of CYP2B10 mRNA CTD PMID:25625231 ciguatoxin CTX1B affects expression ISO RGD:1558311 6480464 Ciguatoxins affects the expression of CYP2B10 mRNA CTD PMID:18353800 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of CYP2B1 mRNA CTD PMID:27225895 , PMID:7587954 ciprofibrate decreases expression ISO RGD:1558311 6480464 ciprofibrate results in decreased expression of CYP2B10 mRNA CTD PMID:27225895 ciprofibrate multiple interactions ISO RGD:1558311 6480464 ciprofibrate inhibits the reaction [1 more ... CTD PMID:17962186 ciprofibrate multiple interactions EXP 6480464 pyridine promotes the reaction [ciprofibrate results in increased expression of CYP2B1 protein] CTD PMID:7587954 citral decreases activity EXP 6480464 citral results in decreased activity of CYP2B1 protein CTD PMID:9242356 citronellal decreases activity EXP 6480464 citronellal results in decreased activity of CYP2B1 protein CTD PMID:9242356 climbazole increases expression EXP 6480464 climbazole results in increased expression of CYP2B1 mRNA, climbazole results in increased expression of CYP2B1 protein CTD PMID:11552297 , PMID:11824557 clofibrate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibrate] results in increased expression of CYP2B1 protein, Clofibrate promotes the reaction [CYP2B1 protein results in increased oxidation of Thiotepa] CTD PMID:10550479 , PMID:2105156 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP2B1 mRNA CTD PMID:11328961 more ... clofibrate increases expression ISO RGD:1558311 6480464 Clofibrate results in increased expression of CYP2B10 mRNA CTD PMID:17627975 clofibric acid multiple interactions EXP 6480464 [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B1 protein] more ... CTD PMID:15788368 clofibric acid increases expression EXP 6480464 Clofibric Acid results in increased expression of CYP2B1 mRNA CTD PMID:15788368 clonazepam increases activity EXP 6480464 Clonazepam results in increased activity of CYP2B1 protein CTD PMID:1372805 clotrimazole multiple interactions EXP 6480464 Clotrimazole inhibits the reaction [CYP2B1 protein results in increased metabolism of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19858067 clotrimazole increases activity EXP 6480464 Clotrimazole results in increased activity of CYP2B1 protein CTD PMID:1372805 clotrimazole multiple interactions ISO RGD:1558311 6480464 NR1I3 protein affects the reaction [Clotrimazole results in increased expression of CYP2B10 mRNA] CTD PMID:12049174 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of CYP2B1 mRNA, Clotrimazole results in increased expression of CYP2B1 protein CTD PMID:36356836 , PMID:7986207 cobalt dichloride decreases expression ISO RGD:1558311 6480464 cobaltous chloride results in decreased expression of CYP2B10 mRNA CTD PMID:21139344 cobalt dichloride increases expression ISO RGD:1558311 6480464 cobaltous chloride results in increased expression of CYP2B10 mRNA CTD PMID:23528251 corticosterone multiple interactions EXP 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B1 protein] CTD PMID:35301062 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CYP2B1 mRNA, Corticosterone results in increased expression of CYP2B1 protein CTD PMID:35301062 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of CYP2B1 mRNA, Hydrocortisone results in increased expression of CYP2B1 protein CTD PMID:10476907 crocidolite asbestos decreases expression ISO RGD:1558311 6480464 Asbestos, Crocidolite results in decreased expression of CYP2B10 mRNA CTD PMID:29279043 cumene hydroperoxide affects oxidation EXP 6480464 CYP2B1 protein affects the oxidation of cumene hydroperoxide CTD PMID:17478480 curcumin affects expression EXP 6480464 Curcumin affects the expression of CYP2B1 protein CTD PMID:16805852 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [CYP2B1 protein results in increased metabolism of nitrosobenzylmethylamine] CTD PMID:16805852 cyanocob(III)alamin multiple interactions ISO RGD:1558311 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA CTD PMID:33549593 cyclophosphamide multiple interactions EXP 6480464 Cyclophosphamide results in increased expression of and results in increased activity of CYP2B1 protein, Metyrapone inhibits the reaction [CYP2B1 results in increased susceptibility to Cyclophosphamide] CTD PMID:16019949 , PMID:7834628 cyclophosphamide increases response to substance EXP 6480464 CYP2B1 protein results in increased susceptibility to Cyclophosphamide, CYP2B1 results in increased susceptibility to Cyclophosphamide CTD PMID:10415877 more ... cyclophosphamide affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Cyclophosphamide CTD PMID:19103281 cyclophosphamide increases activity EXP 6480464 CYP2B1 results in increased activity of Cyclophosphamide CTD PMID:2272335 , PMID:9592392 cyclophosphamide increases hydroxylation EXP 6480464 CYP2B1 protein mutant form results in increased hydroxylation of Cyclophosphamide, CYP2B1 protein results in increased hydroxylation of Cyclophosphamide CTD PMID:11221871 , PMID:15102956 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of CYP2B1 mRNA, Cyclophosphamide results in increased expression of CYP2B1 protein CTD PMID:16019949 , PMID:17634551 cyclophosphamide increases expression ISO RGD:1558311 6480464 Cyclophosphamide results in increased expression of CYP2B10 mRNA CTD PMID:24819615 cyclophosphamide increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Cyclophosphamide, CYP2B1 results in increased metabolism of Cyclophosphamide CTD PMID:15102956 , PMID:20566340 cyhalothrin increases activity EXP 6480464 cyhalothrin results in increased activity of CYP2B1 protein CTD PMID:29727961 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of CYP2B1 mRNA CTD PMID:29727961 cylindrospermopsin decreases expression ISO RGD:1558311 6480464 cylindrospermopsin results in decreased expression of CYP2B10 mRNA CTD PMID:20936652 cypermethrin decreases activity ISO RGD:1558311 6480464 cypermethrin results in decreased activity of CYP2B10 protein CTD PMID:18420780 cypermethrin increases expression ISO RGD:1558311 6480464 cypermethrin results in increased expression of CYP2B10 mRNA CTD PMID:31659573 cypermethrin multiple interactions ISO RGD:1558311 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP2B10 mRNA] CTD PMID:31659573 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CYP2B1 mRNA CTD PMID:11377398 more ... cyproconazole increases activity EXP 6480464 cyproconazole results in increased activity of CYP2B1 protein CTD PMID:25182419 , PMID:29038839 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B1 mRNA more ... CTD PMID:29038839 cyproconazole increases expression ISO RGD:1558311 6480464 cyproconazole results in increased expression of CYP2B10 mRNA, cyproconazole results in increased expression of CYP2B10 protein CTD PMID:17557908 more ... cyproconazole multiple interactions ISO RGD:1558311 6480464 NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP2B10 mRNA] more ... CTD PMID:17557908 , PMID:25656644 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP2B1 mRNA CTD PMID:25182419 , PMID:29038839 cyproterone increases expression ISO RGD:1558311 6480464 Cyproterone results in increased expression of CYP2B10 mRNA CTD PMID:7771797 cyproterone acetate increases expression ISO RGD:1558311 6480464 Cyproterone Acetate results in increased expression of CYP2B10 mRNA CTD PMID:28541575 DDD increases expression EXP 6480464 Dichlorodiphenyldichloroethane results in increased expression of CYP2B1 mRNA CTD PMID:21259292 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP2B1 more ... CTD PMID:12869653 , PMID:21512963 DDT multiple interactions EXP 6480464 [DDT co-treated with Diethylnitrosamine] results in decreased expression of CYP2B1 mRNA, [DDT co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA CTD PMID:15885732 DDT increases expression ISO RGD:1558311 6480464 DDT results in increased expression of CYP2B10 mRNA CTD PMID:23684557 DDT multiple interactions ISO RGD:1558311 6480464 [Androstanols co-treated with fulvestrant] inhibits the reaction [DDT results in increased expression of CYP2B10 mRNA] more ... CTD PMID:23684557 DDT increases activity EXP 6480464 DDT results in increased activity of CYP2B1 protein CTD PMID:1372805 DDT increases expression EXP 6480464 DDT results in increased expression of CYP2B1 protein CTD PMID:11948501 more ... decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CYP2B1 mRNA, decabromobiphenyl ether results in increased expression of CYP2B1 protein CTD PMID:18495385 more ... decabromodiphenyl ether increases expression ISO RGD:1558311 6480464 decabromobiphenyl ether results in increased expression of CYP2B10 mRNA CTD PMID:17324954 , PMID:23531792 decabromodiphenyl ether multiple interactions ISO RGD:1558311 6480464 NR1I2 protein promotes the reaction [decabromobiphenyl ether results in increased expression of CYP2B10 mRNA], NR1I3 gene mutant form inhibits the reaction [decabromobiphenyl ether results in increased expression of CYP2B10 mRNA] CTD PMID:17324954 , PMID:23531792 decabromodiphenyl ether increases activity EXP 6480464 decabromobiphenyl ether results in increased activity of CYP2B1 protein CTD PMID:18495385 deoxycholic acid multiple interactions EXP 6480464 Deoxycholic Acid results in decreased expression of and results in decreased activity of CYP2B1 protein, Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of and results in decreased activity of CYP2B1 protein] CTD PMID:10453939 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [2 more ... CTD PMID:2105156 , PMID:23770461 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP2B1 mRNA CTD PMID:11328961 more ... dexamethasone increases expression ISO RGD:1558311 6480464 Dexamethasone results in increased expression of CYP2B10 mRNA CTD PMID:17627975 more ... dextran sulfate decreases activity EXP 6480464 Dextran Sulfate results in decreased activity of CYP2B1 protein CTD PMID:28438436 dextran sulfate multiple interactions ISO RGD:1558311 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2B10 mRNA CTD PMID:29950665 dextran sulfate multiple interactions EXP 6480464 [Dextran Sulfate results in decreased activity of CYP2B1 protein] which results in decreased chemical synthesis of hydroxybupropion CTD PMID:28438436 dextromethorphan decreases activity ISO RGD:1558311 6480464 Dextromethorphan results in decreased activity of CYP2B10 protein CTD PMID:18420780 Diallyl sulfide multiple interactions ISO RGD:1558311 6480464 NR1I3 protein promotes the reaction [allyl sulfide results in increased expression of CYP2B10 mRNA] CTD PMID:17353348 Diallyl sulfide increases activity EXP 6480464 allyl sulfide results in increased activity of CYP2B1 protein CTD PMID:1372805 Diallyl sulfide increases expression ISO RGD:1558311 6480464 allyl sulfide results in increased expression of CYP2B10 mRNA CTD PMID:15919853 more ... Diallyl sulfide multiple interactions EXP 6480464 NR1I3 protein promotes the reaction [allyl sulfide results in increased expression of CYP2B1 mRNA] CTD PMID:11752103 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of CYP2B1 mRNA, allyl sulfide results in increased expression of CYP2B1 protein CTD PMID:10945841 more ... diallyl trisulfide multiple interactions EXP 6480464 diallyl trisulfide inhibits the reaction [n-hexane results in increased activity of CYP2B1 protein] CTD PMID:28115069 diazepam increases expression ISO RGD:1558311 6480464 Diazepam results in increased expression of CYP2B10 protein CTD PMID:16684660 diazepam increases expression EXP 6480464 Diazepam results in increased expression of CYP2B1 protein CTD PMID:16684660 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CYP2B1 mRNA, Dibutyl Phthalate results in increased expression of CYP2B1 protein CTD PMID:15901914 dibutyl phthalate decreases activity EXP 6480464 Dibutyl Phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 diclofenac decreases activity ISO RGD:1558311 6480464 Diclofenac results in decreased activity of CYP2B10 protein CTD PMID:18420780 dicofol increases expression EXP 6480464 Dicofol results in increased expression of CYP2B1 protein CTD PMID:19595748 Dicyclohexyl phthalate decreases activity EXP 6480464 dicyclohexyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 dieldrin multiple interactions ISO RGD:1558311 6480464 NR1I3 protein affects the reaction [Dieldrin results in increased expression of CYP2B10 mRNA] CTD PMID:12049174 , PMID:32435917 dieldrin increases expression ISO RGD:1558311 6480464 Dieldrin results in increased expression of CYP2B10 mRNA CTD PMID:32435917 diethyl phthalate decreases activity EXP 6480464 diethyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 diethyldithiocarbamic acid increases expression EXP 6480464 Ditiocarb results in increased expression of CYP2B1 mRNA CTD PMID:8390837 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CYP2B1 mRNA CTD PMID:7513451 digitonin increases expression ISO RGD:1558311 6480464 Digitonin results in increased expression of CYP2B10 protein CTD PMID:36030841 dihydroergotamine decreases activity ISO RGD:1558311 6480464 Dihydroergotamine results in decreased activity of CYP2B10 protein CTD PMID:18420780 diiodine multiple interactions ISO RGD:1558311 6480464 [Iodine deficiency co-treated with Propylthiouracil] results in increased expression of CYP2B10 mRNA CTD PMID:22503787 Dimethyl phthalate decreases activity EXP 6480464 dimethyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 dimethyl sulfoxide multiple interactions EXP 6480464 Dimethyl Sulfoxide inhibits the reaction [CYP2B1 protein results in increased metabolism of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19858067 dimethyl sulfoxide multiple interactions ISO RGD:1558311 6480464 [Phenobarbital co-treated with Dimethyl Sulfoxide] results in increased expression of CYP2B10 protein, NR1I3 gene mutant form inhibits the reaction [[Phenobarbital co-treated with Dimethyl Sulfoxide] results in increased expression of CYP2B10 protein] CTD PMID:20371638 dimethylarsinic acid multiple interactions EXP 6480464 [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA, [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein CTD PMID:12115560 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of CYP2B1 mRNA CTD PMID:17481689 dioxygen multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP2B1 protein more ... CTD PMID:26747958 dioxygen decreases activity EXP 6480464 Oxygen deficiency results in decreased activity of CYP2B1 protein CTD PMID:32416225 dipropyl phthalate decreases activity EXP 6480464 di-n-propylphthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 disodium selenite multiple interactions ISO RGD:1558311 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP2B10 mRNA] CTD PMID:31659573 disulfiram multiple interactions EXP 6480464 GH1 protein inhibits the reaction [Disulfiram results in increased expression of CYP2B1 mRNA] CTD PMID:8390837 disulfiram increases expression EXP 6480464 Disulfiram results in increased expression of CYP2B1 mRNA CTD PMID:8390837 elemental selenium increases expression ISO RGD:1558311 6480464 Selenium deficiency results in increased expression of CYP2B10 mRNA CTD PMID:16170372 endosulfan multiple interactions ISO RGD:1558311 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP2B6 protein, [Endosulfan inhibits the reaction [androst-16-en-3-ol results in decreased activity of NR1I3 protein]] which results in increased expression of CYP2B6 mRNA CTD PMID:20361990 , PMID:22515965 endosulfan increases expression ISO RGD:1558311 6480464 Endosulfan analog results in increased expression of CYP2B10 mRNA, Endosulfan results in increased expression of CYP2B10 mRNA CTD PMID:29702342 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of CYP2B1 mRNA CTD PMID:29391264 enilconazole increases expression ISO RGD:1558311 6480464 enilconazole results in increased expression of CYP2B10 CTD PMID:27853109 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CYP2B1 mRNA CTD PMID:25182419 , PMID:29038839 epoxiconazole decreases expression ISO RGD:1558311 6480464 epoxiconazole results in decreased expression of CYP2B10 mRNA CTD PMID:35436446 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B1 mRNA more ... CTD PMID:29038839 epoxiconazole increases expression ISO RGD:1558311 6480464 epoxiconazole results in increased expression of CYP2B10 mRNA CTD PMID:22334560 , PMID:23970803 epoxiconazole increases activity EXP 6480464 epoxiconazole results in increased activity of CYP2B1 protein CTD PMID:25182419 , PMID:29038839 Erionite decreases expression ISO RGD:1558311 6480464 erionite results in decreased expression of CYP2B10 mRNA CTD PMID:29279043 estriol increases expression ISO RGD:1558311 6480464 Estriol results in increased expression of CYP2B10 mRNA CTD PMID:7771797 estrone increases expression ISO RGD:1558311 6480464 Estrone results in increased expression of CYP2B10 mRNA CTD PMID:11075820 more ... ethanol increases expression ISO RGD:1558311 6480464 Ethanol results in increased expression of CYP2B10 mRNA, Ethanol results in increased expression of CYP2B10 protein CTD PMID:19167417 , PMID:27765815 ethanol multiple interactions ISO RGD:1558311 6480464 Ethanol promotes the reaction [SP1 protein binds to CYP2B10 promoter] more ... CTD PMID:27765815 ethanol multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP2B1 protein more ... CTD PMID:26747958 , PMID:35301062 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP2B1 mRNA, Ethanol results in increased expression of CYP2B1 protein CTD PMID:23273579 more ... ethoxyquin increases expression ISO RGD:1558311 6480464 Ethoxyquin results in increased expression of CYP2B10 mRNA CTD PMID:17627975 ethylbenzene increases expression EXP 6480464 ethylbenzene results in increased expression of CYP2B1 protein CTD PMID:1417939 , PMID:8135039 ethylparaben decreases activity EXP 6480464 ethyl-p-hydroxybenzoate results in decreased activity of CYP2B1 protein CTD PMID:27432241 farnesol increases activity EXP 6480464 Farnesol results in increased activity of CYP2B1 protein CTD PMID:15840382 fenarimol multiple interactions ISO RGD:1558311 6480464 [fenarimol co-treated with acephate] affects the expression of CYP2B1 protein more ... CTD PMID:17686559 fenbuconazole multiple interactions ISO RGD:1558311 6480464 fenbuconazole binds to and results in increased activity of CYP2B10 protein CTD PMID:16542693 fenbuconazole increases expression ISO RGD:1558311 6480464 fenbuconazole results in increased expression of CYP2B10 protein CTD PMID:16542693 fenofibrate increases expression ISO RGD:1558311 6480464 Fenofibrate results in increased expression of CYP2B10 mRNA CTD PMID:11798191 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of CYP2B1 mRNA CTD PMID:19118567 fentanyl increases activity ISO RGD:1558311 6480464 Fentanyl results in increased activity of CYP2B6 protein CTD PMID:35914676 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of CYP2B1 mRNA CTD PMID:11377398 fipronil multiple interactions ISO RGD:1558311 6480464 NR1I3 gene mutant form inhibits the reaction [fipronil results in increased expression of CYP2B10 mRNA] CTD PMID:23962444 fipronil increases expression EXP 6480464 fipronil results in increased expression of CYP2B1 mRNA CTD PMID:23962444 fipronil increases expression ISO RGD:1558311 6480464 fipronil results in increased expression of CYP2B10 mRNA CTD PMID:23962444 fluconazole increases expression ISO RGD:1558311 6480464 Fluconazole results in increased expression of CYP2B10 mRNA CTD PMID:16730040 , PMID:25656644 fluconazole multiple interactions ISO RGD:1558311 6480464 NR1I3 promotes the reaction [Fluconazole results in increased expression of CYP2B10 mRNA] CTD PMID:25656644 flumequine multiple interactions ISO RGD:1558311 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 fluoren-9-one increases expression EXP 6480464 9-fluorenone results in increased expression of CYP2B1 protein CTD PMID:10445401 fluorene increases expression EXP 6480464 fluorene results in increased expression of CYP2B1 protein CTD PMID:10445401 folic acid multiple interactions ISO RGD:1558311 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYP2B10 mRNA CTD PMID:22872676 , PMID:33549593 fulvestrant multiple interactions ISO RGD:1558311 6480464 [Androstanols co-treated with fulvestrant] inhibits the reaction [DDT results in increased expression of CYP2B10 mRNA] CTD PMID:23684557 gadolinium trichloride multiple interactions EXP 6480464 gadolinium chloride inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] more ... CTD PMID:10918498 , PMID:18202523 gallocatechin multiple interactions ISO RGD:1558311 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA CTD PMID:25663641 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of CYP2B1 mRNA, Hexachlorocyclohexane results in increased expression of CYP2B1 protein CTD PMID:11684361 more ... gamma-hexachlorocyclohexane multiple interactions EXP 6480464 Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP2B1 protein more ... CTD PMID:18486174 gamma-hexachlorocyclohexane increases activity EXP 6480464 Hexachlorocyclohexane results in increased activity of CYP2B1 protein CTD PMID:11684361 , PMID:12842176 gamma-terpinene decreases activity EXP 6480464 gamma-terpinene results in decreased activity of CYP2B1 protein CTD PMID:9242356 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CYP2B1 mRNA CTD PMID:33387578 geranial decreases activity EXP 6480464 citral results in decreased activity of CYP2B1 protein CTD PMID:9242356 ginsenoside Rg1 multiple interactions EXP 6480464 ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA], ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 protein] CTD PMID:32198087 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP2B1 mRNA CTD PMID:24136188 glycine betaine multiple interactions ISO RGD:1558311 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA CTD PMID:33549593 griseofulvin affects expression ISO RGD:1558311 6480464 Griseofulvin affects the expression of CYP2B10 mRNA CTD PMID:12735108 guggulsterone affects expression ISO RGD:1558311 6480464 pregna-4 more ... CTD PMID:15833898 GW 7647 multiple interactions EXP 6480464 GW 7647 promotes the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:19631232 hemin multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP2B1 protein more ... CTD PMID:26747958 heroin increases activity ISO RGD:1558311 6480464 Heroin results in increased activity of CYP2B6 protein CTD PMID:35914676 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of CYP2B1 protein CTD PMID:10696772 hexane multiple interactions EXP 6480464 diallyl trisulfide inhibits the reaction [n-hexane results in increased activity of CYP2B1 protein] CTD PMID:28115069 hexane increases activity EXP 6480464 n-hexane results in increased activity of CYP2B1 protein CTD PMID:28115069 hydrogen peroxide multiple interactions EXP 6480464 Hydrogen Peroxide inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:11353799 hydroquinone multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone CTD PMID:8211999 Hydroxybupropion multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Bupropion] which results in increased chemical synthesis of hydroxybupropion, [Dextran Sulfate results in decreased activity of CYP2B1 protein] which results in decreased chemical synthesis of hydroxybupropion CTD PMID:28438436 Hydroxybupropion increases chemical synthesis EXP 6480464 CYP2B1 protein results in increased chemical synthesis of hydroxybupropion CTD PMID:28438436 ifosfamide multiple interactions EXP 6480464 [CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil] more ... CTD PMID:10415877 more ... ifosfamide increases response to substance EXP 6480464 CYP2B1 results in increased susceptibility to Ifosfamide CTD PMID:10415877 more ... ifosfamide increases activity EXP 6480464 CYP2B1 results in increased activity of Ifosfamide CTD PMID:2272335 , PMID:9592392 ifosfamide increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Ifosfamide, CYP2B1 results in increased metabolism of Ifosfamide CTD PMID:10415877 , PMID:15102956 ifosfamide increases hydroxylation EXP 6480464 CYP2B1 protein mutant form results in increased hydroxylation of Ifosfamide CTD PMID:15102956 imperatorin increases expression ISO RGD:1558311 6480464 imperatorin results in increased expression of CYP2B10 protein CTD PMID:18692084 indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of CYP2B1, indole-3-carbinol results in increased expression of CYP2B1 protein CTD PMID:8384853 , PMID:9806166 inulin multiple interactions ISO RGD:1558311 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP2B10 mRNA CTD PMID:36331819 isopimpinellin increases expression ISO RGD:1558311 6480464 isopimpinellin results in increased expression of CYP2B10 mRNA, isopimpinellin results in increased expression of CYP2B10 protein CTD PMID:18692084 isopimpinellin multiple interactions ISO RGD:1558311 6480464 NR1I3 protein affects the reaction [isopimpinellin results in increased expression of CYP2B10 mRNA] CTD PMID:18692084 isoprenaline increases expression ISO RGD:1558311 6480464 Isoproterenol results in increased expression of CYP2B10 mRNA CTD PMID:20003209 Isosafrole multiple interactions EXP 6480464 isosafrole promotes the reaction [CYP2B1 protein results in increased oxidation of Thiotepa] CTD PMID:2105156 ivermectin decreases activity ISO RGD:1558311 6480464 Ivermectin results in decreased activity of CYP2B10 protein CTD PMID:18420780 ivermectin increases expression ISO RGD:1558311 6480464 Ivermectin results in increased expression of CYP2B10 mRNA CTD PMID:24998875 ketamine increases expression EXP 6480464 Ketamine results in increased expression of CYP2B1 protein CTD PMID:16076768 ketoconazole multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP2B1 protein results in increased metabolism of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19858067 ketoconazole increases expression ISO RGD:1558311 6480464 Ketoconazole results in increased expression of CYP2B10 mRNA CTD PMID:17966066 ketoconazole decreases activity ISO RGD:1558311 6480464 Ketoconazole results in decreased activity of CYP2B10 protein CTD PMID:18420780 kojic acid multiple interactions ISO RGD:1558311 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B10 mRNA CTD PMID:17917374 L-ascorbic acid multiple interactions ISO RGD:1558311 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B10 mRNA CTD PMID:17917374 L-methionine multiple interactions ISO RGD:1558311 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA more ... CTD PMID:22872676 more ... lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of CYP2B1 protein CTD PMID:9152597 lead diacetate decreases expression ISO RGD:1558311 6480464 lead acetate results in decreased expression of CYP2B10 mRNA CTD PMID:21829687 limonene decreases activity EXP 6480464 limonene results in decreased activity of CYP2B1 protein CTD PMID:9242356 linuron affects activity EXP 6480464 Linuron affects the activity of CYP2B1 protein CTD PMID:7823289 lithocholic acid increases expression ISO RGD:1558311 6480464 Lithocholic Acid results in increased expression of CYP2B10 mRNA CTD PMID:15358766 lithocholic acid decreases activity ISO RGD:1558311 6480464 Lithocholic Acid results in decreased activity of CYP2B10 protein CTD PMID:18420780 lithocholic acid multiple interactions ISO RGD:1558311 6480464 [1 more ... CTD PMID:15358766 more ... lycopene multiple interactions ISO RGD:1558311 6480464 Lycopene promotes the reaction [Atrazine results in increased expression of CYP2B10 mRNA] CTD PMID:36216167 m-tolualdehyde decreases activity EXP 6480464 3-methylbenzaldehyde results in decreased activity of CYP2B1 protein CTD PMID:12791539 m-xylene affects activity EXP 6480464 3-xylene affects the activity of CYP2B1 protein CTD PMID:15204773 , PMID:8296328 m-xylene decreases activity EXP 6480464 3-xylene results in decreased activity of CYP2B1 protein CTD PMID:12791539 more ... m-xylene increases expression EXP 6480464 3-xylene results in increased expression of CYP2B1 protein CTD PMID:8135039 m-xylene multiple interactions EXP 6480464 [3-xylene results in decreased activity of CYP2B1 protein] which affects the metabolism of Benzo(a)pyrene CTD PMID:1949897 mangiferin increases activity EXP 6480464 mangiferin results in increased activity of CYP2B1 protein CTD PMID:18053976 Meclizine multiple interactions ISO RGD:1558311 6480464 [Meclizine binds to and results in increased activity of NR1I3 protein] which results in increased expression of CYP2B10 mRNA CTD PMID:15272053 MeIQx multiple interactions ISO RGD:1558311 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 mephenytoin decreases activity ISO RGD:1558311 6480464 Mephenytoin results in decreased activity of CYP2B10 protein CTD PMID:18420780 mercury dichloride increases expression ISO RGD:1558311 6480464 Mercuric Chloride results in increased expression of CYP2B10 mRNA CTD PMID:24472606 metazachlor increases expression EXP 6480464 metazachlor results in increased expression of CYP2B1 mRNA CTD PMID:31465819 metformin increases expression ISO RGD:1558311 6480464 Metformin results in increased expression of CYP2B10 mRNA CTD PMID:22342832 methidathion increases expression ISO RGD:1558311 6480464 methidathion results in increased expression of CYP2B10 mRNA CTD PMID:34813904 methoxsalen decreases activity EXP 6480464 Methoxsalen results in decreased activity of CYP2B1 protein CTD PMID:15879494 methoxsalen decreases activity ISO RGD:1558311 6480464 Methoxsalen results in decreased activity of CYP2B10 protein CTD PMID:18420780 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CYP2B1 mRNA, Methoxychlor results in increased expression of CYP2B1 protein CTD PMID:14613717 more ... methoxychlor decreases activity ISO RGD:1558311 6480464 Methoxychlor results in decreased activity of CYP2B10 protein CTD PMID:18420780 methoxychlor decreases methylation EXP 6480464 CYP2B1 protein results in decreased methylation of Methoxychlor CTD PMID:12433799 , PMID:7895613 methoxychlor increases hydroxylation EXP 6480464 CYP2B1 protein results in increased hydroxylation of Methoxychlor CTD PMID:7895613 methylarsonic acid multiple interactions EXP 6480464 [monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA, [monomethylarsonic acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein CTD PMID:12115560 methylarsonic acid increases expression EXP 6480464 monomethylarsonic acid results in increased expression of CYP2B1 mRNA CTD PMID:17481689 metolachlor increases activity EXP 6480464 metolachlor results in increased activity of CYP2B1 protein CTD PMID:10813365 metyrapone multiple interactions EXP 6480464 Metyrapone inhibits the reaction [CYP2B1 results in increased susceptibility to Cyclophosphamide], Metyrapone inhibits the reaction [CYP2B1 results in increased susceptibility to Ifosfamide] CTD PMID:7834628 metyrapone increases expression EXP 6480464 Metyrapone results in increased expression of CYP2B1 mRNA CTD PMID:16125621 midazolam decreases activity ISO RGD:1558311 6480464 Midazolam results in decreased activity of CYP2B10 protein CTD PMID:18420780 mifepristone increases expression EXP 6480464 Mifepristone results in increased expression of CYP2B1 mRNA CTD PMID:16125621 mirex increases expression EXP 6480464 Mirex results in increased expression of CYP2B1 mRNA, Mirex results in increased expression of CYP2B1 protein CTD PMID:1715015 mirex multiple interactions ISO RGD:1558311 6480464 Mirex results in increased expression of and results in increased activity of CYP2B10 protein CTD PMID:8722114 mitomycin C multiple interactions EXP 6480464 Mitomycin affects the reaction [CYP2B1 results in increased susceptibility to Ifosfamide] CTD PMID:10415877 monobenzyl phthalate decreases activity EXP 6480464 mono-benzyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 Monobutylphthalate decreases activity EXP 6480464 monobutyl phthalate results in decreased activity of CYP2B1 protein CTD PMID:27432241 monocrotaline multiple interactions ISO RGD:1558311 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA CTD PMID:21224054 monosodium L-glutamate increases expression ISO RGD:1558311 6480464 Sodium Glutamate results in increased expression of CYP2B10 mRNA CTD PMID:20111022 monosodium L-glutamate multiple interactions ISO RGD:1558311 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA more ... CTD PMID:19001666 more ... morphine increases activity ISO RGD:1558311 6480464 Morphine results in increased activity of CYP2B6 protein CTD PMID:35914676 musk xylene increases expression ISO RGD:1558311 6480464 musk xylene metabolite results in increased expression of CYP2B1 mRNA, musk xylene results in increased expression of CYP2B1 mRNA CTD PMID:9397191 musk xylene increases expression EXP 6480464 musk xylene results in increased expression of CYP2B1 mRNA, musk xylene results in increased expression of CYP2B1 protein CTD PMID:10630706 musk xylene multiple interactions ISO RGD:1558311 6480464 musk xylene inhibits the reaction [Phenobarbital results in increased activity of CYP2B1 protein] CTD PMID:9441723 musk xylene affects activity EXP 6480464 musk xylene affects the activity of CYP2B1 protein CTD PMID:10630706 N'-(2,4-dimethylphenyl)-N-methylformamidine increases expression EXP 6480464 U 40481 results in increased expression of CYP2B1 protein CTD PMID:31029719 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of CYP2B1 gene CTD PMID:33148267 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine promotes the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:11353799 , PMID:14722249 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1558311 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP2B1 protein] CTD PMID:18835339 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases activity ISO RGD:1558311 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased activity of CYP2B1 protein CTD PMID:18835339 N-Nitrosodi-n-butylamine increases hydroxylation EXP 6480464 CYP2B1 protein results in increased hydroxylation of dibutylnitrosamine CTD PMID:8625499 N-Nitrosodi-n-propylamine increases hydroxylation EXP 6480464 CYP2B1 protein results in increased hydroxylation of N-nitroso(di-n-propyl)amine CTD PMID:8625499 N-Nitrosodi-n-propylamine decreases nitrosation EXP 6480464 CYP2B1 protein results in decreased nitrosation of N-nitroso(di-n-propyl)amine CTD PMID:10910959 N-Nitrosodi-n-propylamine affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of N-nitroso(di-n-propyl)amine CTD PMID:10910959 N-nitrosodiethylamine multiple interactions EXP 6480464 [Cacodylic Acid co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA more ... CTD PMID:10550479 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CYP2B1 mRNA CTD PMID:21763762 N-nitrosodiethylamine multiple interactions ISO RGD:1558311 6480464 [2 more ... CTD PMID:15492232 more ... N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CYP2B1 mRNA CTD PMID:22037397 NADP zwitterion multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with NADP] results in decreased activity of CYP2B1 protein CTD PMID:11805216 , PMID:16485904 NADP(+) multiple interactions EXP 6480464 [Ethinyl Estradiol co-treated with NADP] results in decreased activity of CYP2B1 protein CTD PMID:11805216 , PMID:16485904 nevirapine increases expression EXP 6480464 Nevirapine metabolite results in increased expression of CYP2B1 mRNA, Nevirapine results in increased expression of CYP2B1 mRNA CTD PMID:23947594 nickel atom decreases expression ISO RGD:1558311 6480464 Nickel results in decreased expression of CYP2B10 mRNA CTD PMID:12540486 nickel sulfate decreases expression ISO RGD:1558311 6480464 nickel sulfate results in decreased expression of CYP2B10 mRNA CTD PMID:16100012 nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 2 more ... CTD PMID:10799646 more ... nicotine increases expression EXP 6480464 Nicotine results in increased expression of CYP2B1 mRNA, Nicotine results in increased expression of CYP2B1 protein CTD PMID:10799646 , PMID:14972772 nicotine increases metabolic processing EXP 6480464 CYP2B1 protein results in increased metabolism of Nicotine CTD PMID:10799646 nifedipine decreases activity ISO RGD:1558311 6480464 Nifedipine results in decreased activity of CYP2B10 protein CTD PMID:18420780 nitrapyrin multiple interactions ISO RGD:1558311 6480464 NR1I3 protein affects the reaction [nitrapyrin results in increased expression of CYP2B10 mRNA] CTD PMID:29159133 nitrapyrin increases expression ISO RGD:1558311 6480464 nitrapyrin results in increased expression of CYP2B10 mRNA, nitrapyrin results in increased expression of CYP2B10 protein CTD PMID:29159133 Nonylphenol increases expression ISO RGD:1558311 6480464 nonylphenol results in increased expression of CYP2B10 mRNA CTD PMID:19041682 Nonylphenol multiple interactions ISO RGD:1558311 6480464 NR1I3 gene mutant form affects the reaction [nonylphenol results in increased expression of CYP2B10 mRNA] CTD PMID:19041682 o-xylene decreases activity EXP 6480464 2-xylene results in decreased activity of CYP2B1 protein CTD PMID:7990171 Octachlorostyrene increases expression ISO RGD:1558311 6480464 octachlorostyrene results in increased expression of CYP2B10 mRNA CTD PMID:19525444 Octachlorostyrene multiple interactions ISO RGD:1558311 6480464 AHR protein inhibits the reaction [octachlorostyrene results in increased expression of CYP2B10 mRNA] CTD PMID:19525444 octamethylcyclotetrasiloxane increases expression EXP 6480464 octamethylcyclotetrasiloxane results in increased expression of CYP2B1 protein CTD PMID:15849718 octamethylcyclotetrasiloxane multiple interactions EXP 6480464 octamethylcyclotetrasiloxane results in increased expression of and results in increased activity of CYP2B1 protein CTD PMID:36100151 okadaic acid multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [2 more ... CTD PMID:23770461 okadaic acid multiple interactions ISO RGD:1558311 6480464 Okadaic Acid inhibits the reaction [Phenobarbital results in increased expression of CYP2B10 mRNA] CTD PMID:27832320 oleanolic acid decreases expression ISO RGD:1558311 6480464 Oleanolic Acid results in decreased expression of CYP2B10 mRNA CTD PMID:23948738 oltipraz affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of oltipraz CTD PMID:15831204 , PMID:15920769 oltipraz increases expression ISO RGD:1558311 6480464 oltipraz results in increased expression of CYP2B10 mRNA CTD PMID:17627975 omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP2B1 mRNA, Omeprazole results in increased expression of CYP2B1 protein CTD PMID:19118567 , PMID:9152597 omeprazole decreases activity ISO RGD:1558311 6480464 Omeprazole results in decreased activity of CYP2B10 protein CTD PMID:18420780 ortho-Aminoazotoluene multiple interactions ISO RGD:1558311 6480464 NR1I3 gene mutant form inhibits the reaction [o-Aminoazotoluene results in increased expression of CYP2B10 mRNA], NR1I3 gene mutant form inhibits the reaction [o-Aminoazotoluene results in increased expression of CYP2B10 protein] CTD PMID:21672546 ortho-Aminoazotoluene increases expression ISO RGD:1558311 6480464 o-Aminoazotoluene results in increased expression of CYP2B10 mRNA, o-Aminoazotoluene results in increased expression of CYP2B10 protein CTD PMID:21672546 Oxadiazon multiple interactions ISO RGD:1558311 6480464 NR1I3 mutant form inhibits the reaction [oxadiazon results in increased expression of CYP2B10 mRNA] CTD PMID:26710982 Oxadiazon increases expression ISO RGD:1558311 6480464 oxadiazon results in increased expression of CYP2B10 mRNA CTD PMID:26710982 oxazepam increases expression EXP 6480464 Oxazepam results in increased expression of CYP2B1 protein CTD PMID:16684660 oxazepam increases expression ISO RGD:1558311 6480464 Oxazepam results in increased expression of CYP2B10 mRNA, Oxazepam results in increased expression of CYP2B10 protein CTD PMID:12727805 more ... oxolane increases activity ISO RGD:1558311 6480464 tetrahydrofuran results in increased activity of CYP2B10 protein CTD PMID:28495613 oxolane multiple interactions ISO RGD:1558311 6480464 NR1I2 protein affects the reaction [tetrahydrofuran results in increased expression of CYP2B10 mRNA], NR1I3 protein affects the reaction [tetrahydrofuran results in increased expression of CYP2B10 mRNA] CTD PMID:28495613 oxolane increases expression ISO RGD:1558311 6480464 tetrahydrofuran results in increased expression of CYP2B10 mRNA CTD PMID:28495613 Oxyfluorfen increases expression ISO RGD:1558311 6480464 oxyfluorofen results in increased expression of CYP2B10 mRNA CTD PMID:22539621 ozone increases expression ISO RGD:1558311 6480464 Ozone results in increased expression of CYP2B6 mRNA CTD PMID:24336422 p-menthan-3-ol increases expression ISO RGD:1558311 6480464 Menthol results in increased expression of CYP2B10 mRNA CTD PMID:24594507 p-xylene increases expression EXP 6480464 4-xylene results in increased expression of CYP2B1 protein CTD PMID:8135039 pantoprazole increases expression EXP 6480464 pantoprazole results in increased expression of CYP2B1 protein CTD PMID:9152597 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP2B1 protein CTD PMID:18798224 paracetamol multiple interactions EXP 6480464 Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP2B1 protein] CTD PMID:18798224 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CYP2B1 mRNA CTD PMID:32680482 parathion affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Parathion CTD PMID:16326433 parathion multiple interactions EXP 6480464 Parathion inhibits the reaction [Phenobarbital results in increased activity of CYP2B1 protein] CTD PMID:15690761 parathion-methyl multiple interactions EXP 6480464 CYP2B1 protein affects the reaction [Methyl Parathion results in decreased activity of ACHE protein] CTD PMID:11684353 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:23770461 PCB138 multiple interactions EXP 6480464 NR1I2 gene mutant form inhibits the reaction [2 more ... CTD PMID:23770461 PCB138 increases activity EXP 6480464 2 more ... CTD PMID:15093247 pentachlorobenzene increases expression EXP 6480464 pentachlorobenzene results in increased expression of CYP2B1 protein CTD PMID:10696772 pentane-2,3-dione decreases expression EXP 6480464 2, 3-pentanedione results in decreased expression of CYP2B1 mRNA CTD PMID:25710175 pentobarbital increases expression EXP 6480464 Pentobarbital results in increased expression of CYP2B1 mRNA, Pentobarbital results in increased expression of CYP2B1 protein CTD PMID:15655285 , PMID:8205533 perfluorobutanesulfonic acid increases expression ISO RGD:1558311 6480464 perfluorobutanesulfonic acid results in increased expression of CYP2B10 mRNA CTD PMID:32534104 perfluorodecanoic acid multiple interactions ISO RGD:1558311 6480464 NR1I3 protein affects the reaction [perfluorodecanoic acid results in increased expression of CYP2B10 mRNA] CTD PMID:18648086 perfluorodecanoic acid increases expression ISO RGD:1558311 6480464 perfluorodecanoic acid results in increased expression of CYP2B10 mRNA CTD PMID:18648086 , PMID:27344344 perfluorododecanoic acid decreases expression ISO RGD:1558311 6480464 perfluorododecanoic acid results in decreased expression of CYP2B10 mRNA CTD PMID:23567314 perfluoroheptanoic acid decreases expression ISO RGD:1558311 6480464 perfluoro-n-heptanoic acid results in decreased expression of CYP2B10 mRNA CTD PMID:23567314 perfluorohexanesulfonic acid increases expression ISO RGD:1558311 6480464 perfluorohexanesulfonic acid results in increased expression of CYP2B10 mRNA CTD PMID:28558994 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of CYP2B1 mRNA CTD PMID:34460931 perfluorononanoic acid increases expression ISO RGD:1558311 6480464 perfluoro-n-nonanoic acid results in increased expression of CYP2B10 mRNA CTD PMID:25543169 , PMID:28558994 perfluorononanoic acid multiple interactions ISO RGD:1558311 6480464 [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in increased expression of CYP2B10 mRNA, [PPARA gene mutant form results in increased susceptibility to perfluoro-n-nonanoic acid] which results in increased expression of CYP2B10 mRNA CTD PMID:25949234 , PMID:33483757 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1558311 6480464 perfluorooctane sulfonic acid results in increased expression of CYP2B10 mRNA CTD PMID:19429403 more ... perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1558311 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP2B10 mRNA CTD PMID:23567314 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1558311 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of CYP2B10 mRNA more ... CTD PMID:20936131 more ... perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid analog results in increased expression of CYP2B1 protein CTD PMID:22245121 perfluorooctanoic acid increases expression ISO RGD:1558311 6480464 perfluorooctanoic acid results in increased expression of CYP2B10 mRNA, perfluorooctanoic acid results in increased expression of CYP2B6 mRNA CTD PMID:17681415 more ... perfluorooctanoic acid decreases expression ISO RGD:1558311 6480464 perfluorooctanoic acid results in decreased expression of CYP2B10 mRNA CTD PMID:22154759 , PMID:23567314 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP2B1 mRNA, perfluorooctanoic acid results in increased expression of CYP2B1 protein CTD PMID:20614104 , PMID:28511854 perfluorooctanoic acid affects expression ISO RGD:1558311 6480464 perfluorooctanoic acid affects the expression of CYP2B10 mRNA CTD PMID:18281256 perfluorooctanoic acid multiple interactions ISO RGD:1558311 6480464 [perfluorooctanoic acid co-treated with Dietary Fats more ... CTD PMID:18467677 more ... perfluoroundecanoic acid decreases expression ISO RGD:1558311 6480464 perfluoroundecanoic acid results in decreased expression of CYP2B10 mRNA CTD PMID:23567314 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of CYP2B1 gene more ... CTD PMID:11377398 more ... permethrin increases expression ISO RGD:1558311 6480464 Permethrin results in increased expression of CYP2B10 mRNA CTD PMID:30629241 permethrin increases expression EXP 6480464 Permethrin results in increased expression of CYP2B1 mRNA CTD PMID:11377398 , PMID:14722249 phenanthrene multiple interactions ISO RGD:1558311 6480464 NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 mRNA], NR1I3 gene mutant form inhibits the reaction [phenanthrene results in increased expression of CYP2B10 protein] CTD PMID:31181217 phenanthrene increases expression ISO RGD:1558311 6480464 phenanthrene results in increased expression of CYP2B10 mRNA, phenanthrene results in increased expression of CYP2B10 protein CTD PMID:31181217 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP2B1 mRNA CTD PMID:20360939 phenethyl caffeate decreases expression EXP 6480464 caffeic acid phenethyl ester results in decreased expression of CYP2B1 protein CTD PMID:22291063 phenformin increases expression EXP 6480464 Phenformin results in increased expression of CYP2B1 mRNA CTD PMID:31324951 phenobarbital increases expression ISO RGD:1558311 6480464 Phenobarbital results in increased expression of CYP2B1 mRNA more ... CTD PMID:10064569 more ... phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP2B1 more ... CTD PMID:10036216 more ... phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of CYP2B1 protein CTD PMID:12458634 more ... phenobarbital affects expression ISO RGD:1558311 6480464 Phenobarbital affects the expression of CYP2B10 mRNA CTD PMID:9007836 phenobarbital multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide co-treated with Phenobarbital] results in increased expression of CYP2B1 mRNA] more ... CTD PMID:10215695 more ... phenobarbital increases activity ISO RGD:1558311 6480464 Phenobarbital results in increased activity of CYP2B1 protein, Phenobarbital results in increased activity of CYP2B10 protein CTD PMID:16542693 more ... phenobarbital multiple interactions ISO RGD:1558311 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA more ... CTD PMID:12049174 more ... phenol multiple interactions EXP 6480464 [CYP2B1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of Phenol CTD PMID:8211999 phenytoin decreases expression EXP 6480464 Phenytoin results in decreased expression of CYP2B1 mRNA CTD PMID:9819145 phenytoin decreases expression ISO RGD:1558311 6480464 Phenytoin results in decreased expression of CYP2B10 protein CTD PMID:19226368 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of CYP2B1 mRNA CTD PMID:10945841 phenytoin multiple interactions ISO RGD:1558311 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA CTD PMID:21224054 phlorizin decreases expression ISO RGD:1558311 6480464 Phlorhizin results in decreased expression of CYP2B6 mRNA CTD PMID:22538082 phorone increases activity EXP 6480464 phorone results in increased activity of CYP2B1 protein CTD PMID:7697745 phorone multiple interactions ISO RGD:1558311 6480464 NFE2L2 gene mutant form inhibits the reaction [phorone results in increased expression of CYP2B10 mRNA] CTD PMID:24494203 phorone increases expression ISO RGD:1558311 6480464 phorone results in increased expression of CYP2B10 mRNA CTD PMID:24494203 phoxim increases expression EXP 6480464 phoxim results in increased expression of CYP2B1 mRNA CTD PMID:36356836 pioglitazone increases expression EXP 6480464 pioglitazone results in increased expression of CYP2B1 mRNA CTD PMID:16597547 pioglitazone increases expression ISO RGD:1558311 6480464 Pioglitazone results in increased expression of CYP2B10 mRNA CTD PMID:28541575 piperonyl butoxide multiple interactions ISO RGD:1558311 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of CYP2B10 mRNA CTD PMID:19690152 , PMID:20101389 piperonyl butoxide increases expression ISO RGD:1558311 6480464 Piperonyl Butoxide results in increased expression of CYP2B10 mRNA CTD PMID:17014948 more ... piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CYP2B1 mRNA CTD PMID:20735435 piperonyl butoxide multiple interactions EXP 6480464 [Permethrin co-treated with Piperonyl Butoxide] results in increased expression of CYP2B1 mRNA, Piperonyl Butoxide inhibits the reaction [Permethrin results in increased expression of CYP2B1 mRNA] CTD PMID:11377398 pirinixic acid multiple interactions EXP 6480464 pirinixic acid promotes the reaction [Phenobarbital results in increased activity of CYP2B1 protein], pirinixic acid promotes the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:18023279 , PMID:19631232 pirinixic acid decreases expression ISO RGD:1558311 6480464 pirinixic acid results in decreased expression of CYP2B10 mRNA CTD PMID:19850644 more ... pirinixic acid increases expression ISO RGD:1558311 6480464 pirinixic acid results in increased expression of CYP2B10 mRNA, pirinixic acid results in increased expression of CYP2B10 protein CTD PMID:11798191 more ... pirinixic acid multiple interactions ISO RGD:1558311 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYP2B10 mRNA more ... CTD PMID:17962186 more ... pravastatin affects expression ISO RGD:1558311 6480464 Pravastatin affects the expression of CYP2B10 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:1558311 6480464 [1 more ... CTD PMID:19433268 more ... pregnenolone 16alpha-carbonitrile affects expression ISO RGD:1558311 6480464 Pregnenolone Carbonitrile affects the expression of CYP2B10 mRNA CTD PMID:31388680 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CYP2B1 mRNA CTD PMID:29548889 pregnenolone 16alpha-carbonitrile multiple interactions EXP 6480464 NR1I2 gene mutant form inhibits the reaction [Pregnenolone Carbonitrile results in increased expression of CYP2B1 mRNA] CTD PMID:29548889 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1558311 6480464 Pregnenolone Carbonitrile results in increased expression of CYP2B10 mRNA, Pregnenolone Carbonitrile results in increased expression of CYP2B10 protein CTD PMID:15986414 more ... prochloraz increases activity EXP 6480464 prochloraz results in increased activity of CYP2B1 protein CTD PMID:25182419 , PMID:29038839 prochloraz multiple interactions EXP 6480464 [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein, [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP2B1 mRNA CTD PMID:29038839 prochloraz increases expression ISO RGD:1558311 6480464 prochloraz results in increased expression of CYP2B10 mRNA, prochloraz results in increased expression of CYP2B10 protein CTD PMID:28058446 , PMID:33150952 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP2B1 mRNA CTD PMID:25182419 , PMID:29038839 progesterone decreases expression ISO RGD:1558311 6480464 Progesterone results in decreased expression of CYP2B10 mRNA CTD PMID:11075820 progesterone increases expression ISO RGD:1558311 6480464 Progesterone results in increased expression of CYP2B10 mRNA CTD PMID:7771797 propachlor increases activity EXP 6480464 propachlor results in increased activity of CYP2B1 protein CTD PMID:10813365 propiconazole multiple interactions ISO RGD:1558311 6480464 NR1H3 gene mutant form inhibits the reaction [propiconazole results in increased expression of CYP2B10 mRNA] CTD PMID:25949234 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP2B1 mRNA, propiconazole results in increased expression of CYP2B1 protein CTD PMID:15603923 more ... propiconazole increases expression ISO RGD:1558311 6480464 propiconazole results in increased expression of CYP2B10 mRNA CTD PMID:15603923 more ... propylbenzene increases expression EXP 6480464 n-propylbenzene results in increased expression of CYP2B1 protein CTD PMID:8135039 propylparaben decreases activity EXP 6480464 propylparaben results in decreased activity of CYP2B1 protein CTD PMID:27432241 propyzamide increases expression ISO RGD:1558311 6480464 pronamide results in increased expression of CYP2B10 mRNA, pronamide results in increased expression of CYP2B10 protein CTD PMID:25092647 propyzamide increases expression EXP 6480464 pronamide results in increased expression of CYP2B1 mRNA CTD PMID:25846364 purpurin increases activity ISO RGD:1558311 6480464 purpurin results in increased activity of CYP2B1 protein CTD PMID:12744663 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of CYP2B1 mRNA CTD PMID:22431067 pyrene increases expression EXP 6480464 pyrene results in increased expression of CYP2B1 mRNA CTD PMID:30240548 pyrene multiple interactions ISO RGD:1558311 6480464 NR1I3 gene mutant form inhibits the reaction [pyrene results in increased expression of CYP2B10 mRNA] CTD PMID:26160115 pyrene increases expression ISO RGD:1558311 6480464 pyrene results in increased expression of CYP2B10 mRNA CTD PMID:17618724 , PMID:26160115 pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of CYP2B1 mRNA CTD PMID:18022748 pyridine increases expression ISO RGD:1558311 6480464 pyridine results in increased expression of CYP2B1 protein CTD PMID:7511897 pyridine increases expression EXP 6480464 pyridine results in increased expression of CYP2B1 mRNA, pyridine results in increased expression of CYP2B1 protein CTD PMID:10215695 more ... pyridine increases activity EXP 6480464 pyridine results in increased activity of CYP2B1 protein CTD PMID:11181506 , PMID:1610360 pyridine affects activity EXP 6480464 pyridine affects the activity of CYP2B1 protein CTD PMID:8246169 pyridine multiple interactions EXP 6480464 INS protein affects the reaction [pyridine results in increased expression of CYP2B1 mRNA] more ... CTD PMID:10215695 , PMID:7587954 quercetin affects expression ISO RGD:1558311 6480464 Quercetin affects the expression of CYP2B10 mRNA CTD PMID:16455785 quercetin multiple interactions ISO RGD:1558311 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of CYP2B10 mRNA CTD PMID:25047408 quercetin decreases activity ISO RGD:1558311 6480464 Quercetin results in decreased activity of CYP2B10 protein CTD PMID:18420780 quinidine decreases activity ISO RGD:1558311 6480464 Quinidine results in decreased activity of CYP2B10 protein CTD PMID:18420780 reactive oxygen species increases abundance EXP 6480464 CYP2B1 results in increased abundance of Reactive Oxygen Species CTD PMID:20407477 reactive oxygen species multiple interactions EXP 6480464 [tetrabromobisphenol A results in increased expression of CYP2B1 protein] which results in increased abundance of Reactive Oxygen Species CTD PMID:24278553 resveratrol decreases activity ISO RGD:1558311 6480464 resveratrol results in decreased activity of CYP2B10 protein CTD PMID:18420780 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP2B1 mRNA CTD PMID:25905778 retinyl acetate decreases expression ISO RGD:1558311 6480464 retinol acetate results in decreased expression of CYP2B10 mRNA CTD PMID:28123100 retinyl acetate multiple interactions ISO RGD:1558311 6480464 [bisphenol A co-treated with retinol acetate] results in increased expression of CYP2B10 mRNA CTD PMID:28123100 Retrorsine increases expression EXP 6480464 retrorsine results in increased expression of CYP2B1 CTD PMID:24799337 rifampicin multiple interactions ISO RGD:1558311 6480464 [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in increased expression of CYP2B10 protein, [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CYP2B10 mRNA CTD PMID:21224054 , PMID:25835148 rifampicin increases expression ISO RGD:1558311 6480464 Rifampin results in increased expression of CYP2B10 mRNA CTD PMID:30503582 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP2B1 mRNA CTD PMID:28374803 selenium atom increases expression ISO RGD:1558311 6480464 Selenium deficiency results in increased expression of CYP2B10 mRNA CTD PMID:16170372 senecionine affects expression ISO RGD:1558311 6480464 senecionine affects the expression of CYP2B10 mRNA CTD PMID:31606820 Shikonin decreases activity EXP 6480464 shikonin results in decreased activity of CYP2B1 protein CTD PMID:28941798 sodium arsenite multiple interactions EXP 6480464 sodium arsenite inhibits the reaction [Phenobarbital results in increased expression of CYP2B1 mRNA] CTD PMID:10329507 sodium arsenite multiple interactions ISO RGD:1558311 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP2B10 mRNA CTD PMID:32045263 sodium chromate multiple interactions EXP 6480464 Carbon Monoxide inhibits the reaction [CYP2B1 protein results in increased reduction of sodium chromate(VI)], Carbon Tetrachloride inhibits the reaction [CYP2B1 protein results in increased reduction of sodium chromate(VI)] CTD PMID:1903091 sodium chromate increases reduction EXP 6480464 CYP2B1 protein results in increased reduction of sodium chromate(VI) CTD PMID:1903091 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of CYP2B1 mRNA CTD PMID:22561333 sodium dichromate decreases expression ISO RGD:1558311 6480464 sodium bichromate results in decreased expression of CYP2B10 mRNA CTD PMID:22155349 stilbene oxide increases expression EXP 6480464 stilbene oxide results in increased expression of CYP2B1 mRNA CTD PMID:10945841 streptozocin multiple interactions ISO RGD:1558311 6480464 Berberine inhibits the reaction [Streptozocin results in increased expression of CYP2B10 mRNA], Streptozocin promotes the reaction [Dietary Fats results in decreased expression of CYP2B10 mRNA] CTD PMID:22342832 , PMID:29382564 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CYP2B1 mRNA CTD PMID:25905778 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP2B1 mRNA CTD PMID:25905778 streptozocin increases expression ISO RGD:1558311 6480464 Streptozocin results in increased expression of CYP2B10 mRNA CTD PMID:22342832 strychnine multiple interactions EXP 6480464 Strychnine results in increased expression of and results in increased degradation of CYP2B1 protein CTD PMID:7906730 styrene multiple interactions EXP 6480464 gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2B1 mRNA], gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP2B1 protein] CTD PMID:18202523 styrene increases expression EXP 6480464 Styrene results in increased expression of CYP2B1 mRNA, Styrene results in increased expression of CYP2B1 protein CTD PMID:16418063 , PMID:18202523 styrene oxide multiple interactions EXP 6480464 CYP2B1 protein promotes the reaction [EPHX1 protein affects the hydrolysis of styrene oxide] CTD PMID:12051674 succimer multiple interactions ISO RGD:1558311 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP2B10 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2B10 mRNA CTD PMID:21641980 , PMID:26378955 Sudan III multiple interactions EXP 6480464 [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] which results in increased activity of CYP2B1 protein] more ... CTD PMID:15788368 Sudan III decreases expression EXP 6480464 sudan III results in decreased expression of CYP2B1 mRNA CTD PMID:15788368 sulfasalazine increases expression ISO RGD:1558311 6480464 Sulfasalazine results in increased expression of CYP2B10 mRNA CTD PMID:31830553 sulfoxaflor increases expression EXP 6480464 sulfoxaflor results in increased expression of CYP2B1 mRNA CTD PMID:23607986 sulfoxaflor increases expression ISO RGD:1558311 6480464 sulfoxaflor results in increased expression of CYP2B10 mRNA CTD PMID:23607986 sulfoxaflor multiple interactions ISO RGD:1558311 6480464 NR1I2 gene mutant form inhibits the reaction [sulfoxaflor results in increased expression of CYP2B10 mRNA], NR1I3 gene mutant form inhibits the reaction [sulfoxaflor results in increased expression of CYP2B10 mRNA] CTD PMID:23607986 tacrine increases expression EXP 6480464 Tacrine analog results in increased expression of CYP2B1 protein, Tacrine results in increased expression of CYP2B1 protein CTD PMID:20533758 tamoxifen affects expression ISO RGD:1558311 6480464 Tamoxifen affects the expression of CYP2B10 mRNA CTD PMID:20937368 tamoxifen multiple interactions ISO RGD:1558311 6480464 [Carbon Tetrachloride co-treated with Tamoxifen] affects the expression of CYP2B10 mRNA CTD PMID:29974145 tamoxifen decreases activity ISO RGD:1558311 6480464 Tamoxifen results in decreased activity of CYP2B10 protein CTD PMID:18420780 tamoxifen increases expression ISO RGD:1558311 6480464 Tamoxifen results in increased expression of CYP2B10 mRNA CTD PMID:7771797 tebuconazole multiple interactions ISO RGD:1558311 6480464 NR1I3 inhibits the reaction [tebuconazole results in increased expression of CYP2B10 mRNA] CTD PMID:25656644 tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of CYP2B1 protein CTD PMID:29923317 tebuconazole increases expression ISO RGD:1558311 6480464 tebuconazole results in increased expression of CYP2B10 mRNA CTD PMID:25656644 tert-butanol increases expression ISO RGD:1558311 6480464 tert-Butyl Alcohol results in increased expression of CYP2B10 mRNA CTD PMID:19760798 tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of CYP2B1 mRNA CTD PMID:24090815 testosterone affects metabolic processing EXP 6480464 CYP2B1 protein affects the metabolism of Testosterone CTD PMID:15879494 testosterone multiple interactions ISO RGD:1558311 6480464 Testosterone metabolite inhibits the reaction [1 more ... CTD PMID:24769335 testosterone decreases activity ISO RGD:1558311 6480464 Testosterone results in decreased activity of CYP2B10 protein CTD PMID:18420780 testosterone decreases expression ISO RGD:1558311 6480464 Testosterone results in decreased expression of CYP2B10 mRNA CTD PMID:11075820 , PMID:21669218 testosterone affects expression ISO RGD:1558311 6480464 Testosterone affects the expression of CYP2B10 mRNA CTD PMID:7771797 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of CYP2B1 protein CTD PMID:7726643 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP2B1 mRNA, Carbon Tetrachloride results in decreased expression of CYP2B1 protein CTD PMID:10445401 , PMID:32380060 tetrachloromethane multiple interactions EXP 6480464 Carbon Tetrachloride inhibits the reaction [CYP2B1 protein results in increased reduction of sodium chromate(VI)] CTD PMID:1903091 tetrachloromethane multiple interactions ISO RGD:1558311 6480464 [Carbon Tetrachloride co-treated with Tamoxifen] affects the expression of CYP2B10 mRNA more ... CTD PMID:16273607 more ... tetrachloromethane increases expression ISO RGD:1558311 6480464 Carbon Tetrachloride results in increased expression of CYP2B10 mRNA CTD PMID:16273607 more ... tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CYP2B1 protein CTD PMID:17606319 tetrahydrocurcumin decreases expression ISO RGD:1558311 6480464 tetrahydrocurcumin results in decreased expression of CYP2B10 mRNA CTD PMID:26102010 Tetramethylthiourea increases expression EXP 6480464 tetramethylthiourea results in increased expression of CYP2B1 protein CTD PMID:10190572 thiabendazole increases expression EXP 6480464 Thiabendazole results in increased expression of CYP2B1 mRNA, Thiabendazole results in increased expression of CYP2B1 protein CTD PMID:15110098 thiacloprid multiple interactions ISO RGD:1558311 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA, [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA CTD PMID:32736067 , PMID:32745781 thiophanate-methyl affects expression EXP 6480464 Thiophanate affects the expression of CYP2B1 protein CTD PMID:10096430 thiophanate-methyl multiple interactions ISO RGD:1558311 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA, [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA CTD PMID:32736067 , PMID:32745781 Thiotepa increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of Thiotepa CTD PMID:2105156 Thiotepa multiple interactions EXP 6480464 Clofibrate promotes the reaction [CYP2B1 protein results in increased oxidation of Thiotepa] more ... CTD PMID:2105156 titanium dioxide decreases expression ISO RGD:1558311 6480464 titanium dioxide results in decreased expression of CYP2B10 mRNA CTD PMID:23131501 , PMID:23557971 titanium dioxide multiple interactions ISO RGD:1558311 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2B10 mRNA CTD PMID:29950665 toluene increases oxidation EXP 6480464 CYP2B1 protein results in increased oxidation of Toluene CTD PMID:1994898 toluene increases expression EXP 6480464 Toluene results in increased expression of CYP2B1 protein CTD PMID:8135039 toluene multiple interactions EXP 6480464 [Phenobarbital results in increased expression of CYP2B1 protein] which results in increased metabolism of Toluene, Phenobarbital promotes the reaction [CYP2B1 protein results in increased oxidation of Toluene] CTD PMID:1994898 , PMID:9010585 toluene 2,4-diisocyanate decreases expression EXP 6480464 Toluene 2 more ... CTD PMID:11043495 toluene 2,4-diisocyanate increases expression EXP 6480464 Toluene 2, 4-Diisocyanate results in increased expression of CYP2B1 CTD PMID:12415424 toxaphene multiple interactions ISO RGD:1558311 6480464 NR1I3 gene mutant form inhibits the reaction [Toxaphene results in increased expression of CYP2B10 mRNA] CTD PMID:26187448 , PMID:28218408 toxaphene increases expression ISO RGD:1558311 6480464 Toxaphene results in increased expression of CYP2B10 mRNA CTD PMID:26187448 , PMID:28218408 trans-1,2-dichloroethene affects expression EXP 6480464 1, 2-dichloroethylene affects the expression of CYP2B1 protein CTD PMID:9493318 tremolite asbestos decreases expression ISO RGD:1558311 6480464 tremolite results in decreased expression of CYP2B10 mRNA CTD PMID:29279043 triadimefon multiple interactions ISO RGD:1558311 6480464 NR1H3 gene mutant form inhibits the reaction [triadimefon results in increased expression of CYP2B10 mRNA] CTD PMID:25949234 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP2B1 mRNA, triadimefon results in increased expression of CYP2B1 protein CTD PMID:17178689 , PMID:17484520 triadimefon increases expression ISO RGD:1558311 6480464 triadimefon results in increased expression of CYP2B10 mRNA CTD PMID:19010342 more ... trichloroethene increases expression ISO RGD:1558311 6480464 Trichloroethylene results in increased expression of CYP2B10 mRNA CTD PMID:19448997 , PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CYP2B1 mRNA CTD PMID:33387578 triclocarban multiple interactions ISO RGD:1558311 6480464 NR1I3 gene mutant form inhibits the reaction [triclocarban results in increased expression of CYP2B10 mRNA], NR1I3 gene mutant form inhibits the reaction [triclocarban results in increased expression of CYP2B10 protein] CTD PMID:22761658 triclocarban increases expression ISO RGD:1558311 6480464 triclocarban results in increased expression of CYP2B10 mRNA, triclocarban results in increased expression of CYP2B10 protein CTD PMID:22761658 triclosan increases expression EXP 6480464 Triclosan results in increased expression of CYP2B1, Triclosan results in increased expression of CYP2B1 mRNA CTD PMID:19910387 more ... trimethylarsine oxide multiple interactions EXP 6480464 [trimethylarsine oxide co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 mRNA, [trimethylarsine oxide co-treated with Diethylnitrosamine] results in increased expression of CYP2B1 protein CTD PMID:12115560 trimethylarsine oxide increases expression EXP 6480464 trimethylarsine oxide results in increased expression of CYP2B1 mRNA CTD PMID:17481689 triphenyl phosphate multiple interactions ISO RGD:1558311 6480464 [tris(1 more ... CTD PMID:29112739 , PMID:32360330 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CYP2B1 mRNA CTD PMID:30589522 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of CYP2B1 mRNA CTD PMID:33600922 Triptolide multiple interactions ISO RGD:1558311 6480464 TRAJ18 protein affects the reaction [triptolide results in decreased expression of CYP2B10 mRNA] CTD PMID:32987112 Triptolide decreases expression ISO RGD:1558311 6480464 triptolide results in decreased expression of CYP2B10 mRNA CTD PMID:32835833 , PMID:32987112 triptonide increases expression ISO RGD:1558311 6480464 triptonide results in increased expression of CYP2B10 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1558311 6480464 troglitazone results in increased expression of CYP2B6 mRNA CTD PMID:28973697 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP2B1 mRNA CTD PMID:16597547 uranium atom increases expression EXP 6480464 Uranium results in increased expression of CYP2B1 mRNA CTD PMID:16039771 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP2B10 mRNA] more ... CTD PMID:10453939 , PMID:32198087 ursodeoxycholic acid affects expression ISO RGD:1558311 6480464 Ursodeoxycholic Acid affects the expression of CYP2B10 protein CTD PMID:16472600 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CYP2B1 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1558311 6480464 Valproic Acid affects the expression of CYP2B10 mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:1558311 6480464 Valproic Acid results in increased expression of CYP2B10 mRNA CTD PMID:24535564 verapamil decreases activity ISO RGD:1558311 6480464 Verapamil results in decreased activity of CYP2B10 protein CTD PMID:18420780 verteporfin multiple interactions ISO RGD:1558311 6480464 Verteporfin inhibits the reaction [1 more ... CTD PMID:29893953 vinclozolin multiple interactions ISO RGD:1558311 6480464 [acephate co-treated with vinclozolin] affects the expression of CYP2B1 protein more ... CTD PMID:17686559 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP2B1 protein CTD PMID:7986207 warfarin decreases activity ISO RGD:1558311 6480464 Warfarin results in decreased activity of CYP2B10 protein CTD PMID:18420780 zaragozic acid A increases expression ISO RGD:1558311 6480464 squalestatin 1 results in increased expression of CYP2B10 mRNA CTD PMID:27225895 zinc atom multiple interactions ISO RGD:1558311 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA CTD PMID:33549593 zinc protoporphyrin multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP2B1 protein CTD PMID:26747958 zinc(0) multiple interactions ISO RGD:1558311 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP2B10 mRNA CTD PMID:33549593 ziram multiple interactions ISO RGD:1558311 6480464 [Dietary Fats co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Captan co-treated with Chlorpyrifos co-treated with thiacloprid co-treated with Thiophanate co-treated with Ziram] results in increased expression of CYP2B10 mRNA, [Ziram co-treated with Thiophanate co-treated with Captan co-treated with Chlorpyrifos co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with thiacloprid] results in increased expression of CYP2B10 mRNA CTD PMID:32736067 , PMID:32745781
